BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9061180)

  • 1. Erosion of composite polymer matrices.
    Göpferich A
    Biomaterials; 1997 Mar; 18(5):397-403. PubMed ID: 9061180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erosion of biodegradable block copolymers made of poly(D,L-lactic acid) and poly(ethylene glycol).
    von Burkersroda F; Gref R; Göpferich A
    Biomaterials; 1997 Dec; 18(24):1599-607. PubMed ID: 9613807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why degradable polymers undergo surface erosion or bulk erosion.
    von Burkersroda F; Schedl L; Göpferich A
    Biomaterials; 2002 Nov; 23(21):4221-31. PubMed ID: 12194525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of double-walled polymer microspheres of PLLA and P(CPP:SA)20:80. I. In vitro degradation.
    Leach KJ; Mathiowitz E
    Biomaterials; 1998 Nov; 19(21):1973-80. PubMed ID: 9863531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fabrication technique on the erosion characteristics of polyanhydride matrices.
    Akbari H; D'Emanuele A; Attwood D
    Pharm Dev Technol; 1998 May; 3(2):251-9. PubMed ID: 9653763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of porous poly(anhydride-co-imide) microspheres and implications for controlled macromolecule delivery.
    Hanes J; Chiba M; Langer R
    Biomaterials; 1998; 19(1-3):163-72. PubMed ID: 9678864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of double-walled polymer microspheres of PLLA and P(CPP:SA)20:80. II. In vivo degradation.
    Leach KJ; Takahashi S; Mathiowitz E
    Biomaterials; 1998 Nov; 19(21):1981-8. PubMed ID: 9863532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic relationships between polymer microstructure and drug release kinetics in bioerodible polyanhydrides.
    Shen E; Kipper MJ; Dziadul B; Lim MK; Narasimhan B
    J Control Release; 2002 Jul; 82(1):115-25. PubMed ID: 12106982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular weight changes in polymer erosion.
    D'Emanuele A; Hill J; Tamada JA; Domb AJ; Langer R
    Pharm Res; 1992 Oct; 9(10):1279-83. PubMed ID: 1448426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release of macromolecules from a degradable polyanhydride matrix.
    Dang W; Saltzman WM
    J Biomater Sci Polym Ed; 1994; 6(3):297-311. PubMed ID: 7527250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulsatile release of parathyroid hormone from an implantable delivery system.
    Liu X; Pettway GJ; McCauley LK; Ma PX
    Biomaterials; 2007 Oct; 28(28):4124-31. PubMed ID: 17576005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injection-molding versus extrusion as manufacturing technique for the preparation of biodegradable implants.
    Rothen-Weinhold A; Besseghir K; Vuaridel E; Sublet E; Oudry N; Kubel F; Gurny R
    Eur J Pharm Biopharm; 1999 Sep; 48(2):113-21. PubMed ID: 10469929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
    Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
    J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo biocompatibility, sustained-release and stability of triptorelin formulations based on a liquid, degradable polymer.
    Asmus LR; Tille JC; Kaufmann B; Melander L; Weiss T; Vessman K; Koechling W; Schwach G; Gurny R; Möller M
    J Control Release; 2013 Feb; 165(3):199-206. PubMed ID: 23220105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of water-soluble additives on drug release kinetics from biodegradable poly(lactic-co-glycolic acid) matrix].
    Song LP; Yang J; Wang H; Sun HF; Tang LN; Wu L; Chang J; Song CX
    Yao Xue Xue Bao; 2005 Jun; 40(6):557-62. PubMed ID: 16144325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterization of polyanhydride for local BCNU delivery carriers.
    Kim MS; Seo KS; Seong HS; Cho SH; Lee HB; Hong KD; Kim SK; Khang G
    Biomed Mater Eng; 2005; 15(3):229-38. PubMed ID: 15912003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of polymer/basic drug interactions on the two-stage diffusion-controlled release from a poly(L-lactic acid) matrix.
    Miyajima M; Koshika A; Okada J; Ikeda M
    J Control Release; 1999 Sep; 61(3):295-304. PubMed ID: 10477802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of propranolol and diclofenac from low Mw DL-poly(lactic acid).
    Mamouzelos NJ; Proikakis CS; Tarantili PA; Andreopoulos AG
    J Biomater Appl; 2002 Jan; 16(3):177-90. PubMed ID: 11939454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H; Bodmeier R
    Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The erosion behaviour of matrix tablets using polyethylene oxide matrices as hydrophilic polymer].
    Nie SF; Tang H; Guo H; Pan WS
    Yao Xue Xue Bao; 2005 Oct; 40(10):882-7. PubMed ID: 16408802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.